Delivery Order SPE2DB22D9304-SPE2DB25FSSY8
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $61,902.91 by the Defense Logistics Agency (DLA) on July 11, 2025, for MACI 3cm x 5cm implant sheets. The delivery order, which carries an ultimate completion date of August 1, 2025, was issued without a set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc. for MACI 3cm x 5cm implant sheets. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The contract carries no set-aside designation and has an ultimate completion date of September 24, 2025. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, and represents no set-aside designation. The award falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. The contract represents a discrete order issued under DMS Pharmaceutical Group's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $53,318.24 contract is for the delivery of MACI 3CM X 5CM implant sheets to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999,...
- The Defense Logistics Agency awarded a $61,538.77 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 15, 2025, for MACI 3cm x 5cm implant sheets, with an ultimate completion date of October 6, 2025. This delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. MACI (matrix-applied characterized autologous mesenchymal cells) implants are advanced regenerative medicine products...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $61,902.91 for MACI 3cm x 5cm implant sheets. The contract, issued on June 26, 2025, with an ultimate completion date of July 18, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $61,902.91 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 26, 2025, for MACI 3cm x 5cm implant sheets, with an ultimate completion date of September 17, 2025. This delivery order was issued without a set-aside designation and represents a discrete procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The Park Ridge, Illinois-based woman-owned...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $61,538.77 by the Defense Logistics Agency (DLA) on August 8, 2025. The delivery order, with an ultimate completion date of August 29, 2025, is for MACI 3cm x 5cm implant sheets—a regenerative medicine product used in cartilage repair and orthopedic applications. This award was issued without a set-aside designation, allowing...
- SPE2DB22D9304Indefinite Delivery Contract
- SPE2DB22D9304-SPE2DB25FSSY8Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, for MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order, valued at approximately $61.9K, is set to be completed by August 28, 2025. The award represents a task order issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with DLA under the SPE2DB program, which carries a $500M ceiling and extends through November 2026. This IDC enables DLA to procure a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare facilities worldwide. MACI (matrix-applied characterized autologous cultured chondrocytes) implants are advanced cartilage regeneration products used in orthopedic surgery. As a prime contractor with no set-aside designation applied to this particular delivery order, DMS Pharmaceutical Group leverages its established position in the federal pharmaceutical supply chain to fulfill medical supply requirements for military health facilities. The company's consistent track record of securing DLA pharmaceutical contracts demonstrates its capability to reliably distribute specialized pharmaceutical products and medical devices across the DoD healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.9k | 8/7/25 |